News and developments


Discover all the information about the research, development and marketing of immunotherapy treatments and natural food supplements for a healthier life.

Probelte Pharma published the protocol for the PROACAROS phase III Beltavac® clinical trial in the TRIALS journal


Murcia, Spain — May 2025 Probelte Pharma has announced that the full protocol for the PROACAROS phase III clinical trial, designed to evaluate the efficacy and safety of Beltavac® subcutaneous…


Read more